CVS Health Takes the Lead in 2025 S&P 500 Chart: Is It a Buy Now?

In a year marked by macroeconomic uncertainty and renewed trade tensions that have shaken the equity market, CVS Health (CVS) has emerged as an unexpected outperformer. After a rough 2024, marked by high utilization at its Aetna insurance unit as well as reimbursement pressure, CVS Health has experienced a dramatic recovery so far in 2025. The stock has become the S&P 500’s top performer, with a year-to-date return exceeding 41%, thereby outperforming all other index members by a significant margin.Image So ...